Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001348268 | SCV001542563 | uncertain significance | Progressive familial heart block type IB | 2023-12-11 | criteria provided, single submitter | clinical testing | This sequence change replaces histidine, which is basic and polar, with proline, which is neutral and non-polar, at codon 849 of the TRPM4 protein (p.His849Pro). This variant is present in population databases (rs572920924, gnomAD 0.001%). This variant has not been reported in the literature in individuals affected with TRPM4-related conditions. ClinVar contains an entry for this variant (Variation ID: 1044070). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004036549 | SCV004971109 | uncertain significance | Cardiovascular phenotype | 2024-03-05 | criteria provided, single submitter | clinical testing | The c.2546A>C (p.H849P) alteration is located in exon 17 (coding exon 17) of the TRPM4 gene. This alteration results from a A to C substitution at nucleotide position 2546, causing the histidine (H) at amino acid position 849 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |